Open AccessDeferiprone or deferasirox for cardiac siderosis in thalassemia major (reply)
Author(s) -
Alessia Pepe,
Giuseppe Rossi,
Antonella Meloni,
Aurelio Maggio
Publication year - 2011
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2010.039479
Subject(s) - deferasirox , deferiprone , thalassemia , siderosis , medicine , beta thalassemia , chelation therapy , deferoxamine , intensive care medicine , pediatrics
These preliminary data confirm deferiprone monotherapy to be more effective than deferasirox in improving myocardial siderosis and a comparable efficacy between deferasirox and desferrioxamine